Clinical Trial Update: Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether adding intra-arterial Angiotensin II to radioembolization improves tumor radiation dose in locally advanced or metastatic liv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Angiotensin II (angiotensin II)

Snippet

Sponsor: Niek Wijnen | Conditions: Liver Cancer (Locally Advanced or Metastatic), Liver Cancer Adult | Phase 2 | Status: RECRUITING